|
RC3H2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.3019364192578E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.91757720813257E-12 |
| Normal-vs-Stage2 |
1.86410000002635E-06 |
| Normal-vs-Stage3 |
1.14190000000125E-06 |
| Normal-vs-Stage4 |
5.57700000000105E-05 |
| Stage1-vs-Stage2 |
3.387200E-01 |
| Stage1-vs-Stage3 |
4.310800E-01 |
| Stage1-vs-Stage4 |
9.289200E-01 |
| Stage2-vs-Stage3 |
8.477200E-01 |
| Stage2-vs-Stage4 |
5.206000E-01 |
| Stage3-vs-Stage4 |
6.405600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.29913873997612E-12 |
| Normal-vs-AfricanAmerican |
6.86560031049055E-10 |
| Normal-vs-Asian |
4.14209999999304E-06 |
| Caucasian-vs-AfricanAmerican |
7.864400E-01 |
| Caucasian-vs-Asian |
6.594000E-02 |
| AfricanAmerican-vs-Asian |
2.624800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.64709999997503E-06 |
| Male-vs-Female |
6.983700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.04930000244252E-08 |
| Normal-vs-Extreme_Weight |
1.6251444634463E-12 |
| Normal-vs-Obese |
5.69100000014089E-07 |
| Normal-vs-Extreme_Obese |
6.15309999951741E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.502150E-01 |
| Normal_Weight-vs-Obese |
2.462000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.502800E-01 |
| Extreme_Weight-vs-Obese |
3.782200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.241000E-01 |
| Obese-vs-Extreme_Obese |
2.548400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.6333000000055E-05 |
| Normal-vs-Age(41-60Yrs) |
2.40020003872132E-09 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
2.13240536339754E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.628000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.155800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.816050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.722400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.197100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.231750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62492241884138E-12 |
| Normal-VS-Type2 PRCC |
2.36110020424007E-10 |
| Normal-VS-KIRP CIMP |
5.724400E-02 |
| Normal-VS-Unclassified PRCC |
5.66679999999264E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.384000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.539100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.159800E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.970200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.947440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.602400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.82662782069565E-13 |
| Normal-vs-N1 |
2.76460000003809E-06 |
| Normal-vs-N2 |
2.139700E-02 |
| N0-vs-N1 |
1.175370E-01 |
| N0-vs-N2 |
3.341400E-01 |
| N1-vs-N2 |
8.779400E-01 |
|
|
